volume. Gross Profit Margin Gross profit margin is equal to 32.30% in 2Q17, which slightly declined from the same period of last year which was 33.83%. The main cause stemmed from the duplicated costs of

% 10.1% EBITDA (MB) 21.9 37.0 -40.8% EBITDA (%) 9.7% 18.0% Earnings per share (Baht) 0.02 0.04 -50.0% Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization Statement of

% 2.2% EBITDA (MB) 27.8 14.9 86.3% EBITDA (%) 14.6% 6.2% Earnings per share (Baht) 0.03 0.01 200.0% Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization Statement of

Financial expenses 1.76 0.30% 1.60 0.33% 0.16 9.98 Share of losses from associates 0.17 0.03% 0 0% 0.17 100 Income tax 8.12 1.37% 6.92 1.42% 1.21 17.44 Net profit 21.14 3.58% 37.03 7.61% (15.89) (42.92

”) No.9/2019 Held on November 26, 2019 at 13.30 hrs. has approved investment in N Hospital Co.,Ltd which engaging in healthcare business, hospital, pharmaceuticals and medical equipment. Share of

clarifies the performance as follows: During the first quarter of 2020, the Company had the total revenue and share of profit and net profit of THB 1,277.8 mm and THB 99.3 mm, respectively. If excluding FX

companies in 2017 was 9,612.85 million THB, decreasing 4,988.67 million THB or 34.17% from that in 2016. More than 90% of the main income was achieved from sale which decreased from 13,855.41 million THB in

from Main Businesses 710.6 100.0% 724.1 100.0% Costs of foods and beverages 253.0 35.6% 263.5 36.7% Other operating expenses 287.1 40.4% 294.1 40.6% Costs of Sales and Service 540.1 76.0% 557.6 77.0

) 9 0 6) The main Revenue f For the six increasing year. The i parent com increased b 83.51 milli For the sec main reaso same perio sales incre by Baht 55 Cost of sal For the six reason was same perio

gross main income of the Company and subsidiary companies in Q3/2018 was 2,290.65 million THB, decreasing 55.83 million THB from Q3/2017 or 2.38% only. But the gross profit from sales has increased 6.82